scPharmaceuticals Inc (FRA:2SX)
€ 3.34 -0.02 (-0.6%) Market Cap: 165.30 Mil Enterprise Value: 128.40 Mil PE Ratio: 0 PB Ratio: 5.86 GF Score: 25/100

Q2 2024 scPharmaceuticals Inc Earnings Call Transcript

Aug 14, 2024 / 08:30PM GMT
Release Date Price: €4.28 (+7.00%)
Operator

Greetings, and welcome to the scPharmaceuticals second-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, PJ Kelleher, Investor Relations. Thank you. You may begin.

PJ Kelleher
LifeSci Advisors - Investor Relations

Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. All statements on this conference call other than historical facts are forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements regarding scPharmaceuticals' expected future financial results, management's expectations and plans for the business, the ongoing commercialization and marketing of FUROSCIX, and the potential label expansion and other regulatory approvals of FUROSCIX.

The words anticipate, believe, estimate, expect, intend, guidance, confidence, target, project, and other similar expressions are used typically

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot